News Center
Contact us
中文
About Us
Who we are
Our history
Brand culture
Our Businesses
Pharma
Medical
Diagnostics
Vaccines
Sustainability
EHS Responsibility
Education Projects
Charitable Donations
Community Services
Join us
People Strategy
Our People
Job Opportunities
News Center
Luye Pharma's Meibirui (Paliperidone Palmitate Injection) Approved for Marketing in China...
2024-06-12
MORE>
NDA for Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Trea...
2024-06-07
MORE>
First in China: BLA for Boan’s Dulaglutide Injection Accepted
2024-05-28
MORE>
Boan’s Boluojia® (Denosumab) Approved for Marketing in China
2024-05-27
MORE>
Boan Biotech Announces 2023 Financial Results
2024-03-26
MORE>
Luye Pharma’s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao
2024-03-07
MORE>
Total:
139
/ Page:
24
First
Prev
2
3
4
5
6
Next
Last
鲁ICP备05023892号-5
LUYE All Rights Reserved
Privacy policy
Terms of use
中文
TOP
TOP